Biohaven (BHVN) Cash from Operations (2021 - 2026)
Biohaven (BHVN) posted Cash from Operations of 149918000.0 for Q1 2026, down 14.74% sequentially from 130662000.0 in Q4 2025, and up 9.21% YoY from 137276436.71 in Q1 2025.
Powered by 
Analysis
Biohaven (BHVN) Cash from Operations (2021 - 2026) Analysis & Trends
Biohaven has reported Cash from Operations for 6 years, with the latest figure at 149918000.0 in Q1 2026.
- Quarterly Cash from Operations rose 9.21% year-over-year to 149918000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 594232000.0 (up 7.86% YoY) and the FY2025 annual result came in at 609438000.0, down 4.63% from the prior year.
- Cash from Operations slipped to 149918000.0 in Q1 2026 per BHVN's latest filing, from 130662000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 44393000.0 in Q2 2023 and troughed at 170742000.0 in Q4 2024.
- A 5-year average of 115954294.12 and a median of 114881000.0 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2023 and 2024: Cash from Operations surged 34.61% in 2023, then slumped 277.98% in 2024.
- Over 5 years, Cash from Operations stood at 75407000.0 in 2022, then sank by 52.35% to 114881000.0 in 2023, then sank by 48.63% to 170742000.0 in 2024, then climbed by 23.47% to 130662000.0 in 2025, then fell by 14.74% to 149918000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 149918000.0, 130662000.0, and 145716000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Biohaven | 2.37 Bn | 2.10 Bn | - | -85.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -85.10 Mn |
| Mar 31, 2026 | -149.92 Mn |
| Dec 31, 2025 | -130.66 Mn |
| Sep 30, 2025 | -145.72 Mn |
| Jun 30, 2025 | -167.94 Mn |
| Mar 31, 2025 | -165.12 Mn |
| Dec 31, 2024 | -170.74 Mn |
| Sep 30, 2024 | -141.28 Mn |
| Jun 30, 2024 | -167.80 Mn |
| Mar 31, 2024 | -102.64 Mn |
| Dec 31, 2023 | -114.88 Mn |
| Sep 30, 2023 | -94.81 Mn |
| Jun 30, 2023 | -44.39 Mn |
| Mar 31, 2023 | -77.64 Mn |
| Dec 31, 2022 | -75.41 Mn |
| Sep 30, 2022 | -95.56 Mn |
| Jun 30, 2022 | -67.89 Mn |
| Mar 31, 2022 | -58.84 Mn |
| Dec 31, 2021 | -33.06 Mn |